-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd_executive.pdf
September 01, 2011 - Layout 1
Background
Gastroesophageal reflux disease (GERD) is
one of the most common health conditions
affecting Americans. A study of an
employed population in the United States
estimated that more than 11,000 of 267,000
employees (4 percent) suffered from
GERD, contributing an average
incremental cost to the emplo…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/health-information-exchange-disposition-160504.pdf
December 15, 2015 - inclusion and exclusion criteria are acceptable but not
well justified beyond the attribution to the AHRQ guidelines … work about effects of PHR-
delivered interventions on medication reconciliation
(Schnipper 2009), diabetes … people taking
medicines, clinicians and guidelines? … We now note this was patient
adherence to taking medications
prescribed based on evidence-based
guidelines
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/venous-ulcers-treatment_executive.pdf
January 01, 2014 - , study period,
followup), study participants (e.g., age, sex, duration
of ulcer, smoking status, diabetes … We collected data on subgroups of interest
(e.g., age, presence of comorbid conditions [diabetes,
obesity … Known
Our findings are in concert with previous published large
reviews and evidence-based practice guidelines
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
March 01, 2013 - This report may be used, in whole or in part, as the basis for development of clinical practice
guidelines … Search strategies are described
elsewhere.14
Following FDA and other professional guidelines,
We … the time
of recruitment, patients with
severe hepatic or renal
disease, glaucoma, or
uncontrolled diabetes … RCT
Taiwan
N: 74
Pregnancy, neurologic
disorders, diabetes mellitus,
demand cardiac pacemaker
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/phenylketonuria_executive.pdf
February 01, 2012 - placebo-controlled trials that adhere to the high
standards required for synthesis and use in treatment
guidelines